Covid: First UK sufferers given take-at-home capsule

It confirmed that in a later, second a part of the trial, there was no vital distinction in outcomes between the group given the drug and an identical group given a dummy capsule or placebo. Combined with the outcomes from the primary a part of the trial, it diminished the general efficacy of the therapy from 50% to 30%.


Leave a Reply

Your email address will not be published.

Back to top button

Adblocker detected! Please consider reading this notice.

We've detected that you are using AdBlock Plus or some other adblocking software which is preventing the page from fully loading. We don't have any banner, Flash, animation, obnoxious sound, or popup ad. We do not implement these annoying types of ads! We need money to operate the site, and almost all of it comes from our online advertising. Please add to your ad blocking whitelist or disable your adblocking software.